Verve Therapeutics Inc VERV

NAS: VERV | ISIN: US92539P1012 11/07/2025

11,03 USD (-0,27%)

(-0,27%) 11/07/2025

Toon enkel gratis nieuws

13 september 2024 · VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm · Persbericht

13 september 2024 · Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for Investors - Contact Levi & Korsinsky · Persbericht

10 september 2024 · Investors who lost money on Verve Therapeutics, Inc.(VERV) should contact Levi & Korsinsky about pending Class Action - VERV · Persbericht

6 september 2024 · Investors who lost money on Verve Therapeutics, Inc.(VERV) should contact Levi & Korsinsky about pending Class Action - VERV · Persbericht

31 augustus 2024 · INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics · Persbericht

19 april 2024 · Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe